News focus

Oral Insulin: All Mouth, or an Injection of Hope for Type 1 Diabetes?

23-May-2013 - Can oral insulin succeed where other alternative delivery methods have failed? Dan Stanton, from in-Pharmatechnologist.com assesses its chances. 

DISPATCHES FROM INTERPHEX

New DFS Unit Built on Technology, R&D and Manufacturing, says Capsugel

22-May-2013 - Following a busy few months, Capsugel spoke about the formation of its Dosage Form Solutions Unit, its technology and the integration of Encap at this year's Interphex in New York.

West Adds Second Filling line in Prep for Future Crystal Zenith Boom

15-May-2013 - Extra filling capacity is to be made available in preparation for West’s Crystal Zenith (CZ) system, though approval and increased sales are still at least 18 months away.

Recipharm to offer new metal-based delivery tech

13-May-2013 - Melding metals to APIs could make drugs easier to deliver according to Sweden's Recipharm which partnered to add a new chemistry to its offering last week.

News in brief

Novo Nordisk $69m Plant Conversion For New Diabetes Drug

06-May-2013 - Novo Nordisk says the $69 investment in its Danish plant will convert capacity ready for its new GLP-1 analogue and is a further commitment to Danish manufacturing.

Updated

Pharma Companies Buzz Over Auto-Injectors Showing Success with High Viscosity Drugs

02-May-2013 - New auto-injector technology that is user-friendly and capable of delivering high viscosity drugs may be the next big thing for pharma and biotech companies pushing further into niche biologics and biosimilars.

Injex Gets China Approval; Glide to Make Solid-Dose Anthrax for Pfenex

30-Apr-2013 - Injex says it is looking for partners to prefill its device and Glide will develop Pfenex’s anthrax vaccine using its solid-dose injector – welcome to our needle-free drug delivery round-up.

LIVE FROM INTERPHEX

Tech and Regulatory Issues? Biotech/Manufacturing Firms Discuss

29-Apr-2013 - Purification bottlenecks, integrating single-use technologies and low cost companies are just some of the issues affecting the biotech industry today, according to experts at this year’s Interphex.

Drug Industry gathers for Interphex 2013 - Check for live updates

23-Apr-2013 - Pharmaceutical conferences are like buses - to paraphrase an old British joke - you wait for one and then three come along at once.

Hikma Opts to Keep its Lucrative Injectable Business

22-Apr-2013 - Despite offers from Amgen and Novartis reportedly worth up to $2bn, Hikma announced last week it will keep its profitable and growing injectable business.

Unilife Signs First Contract for its EZMix Dual-Chamber Syringe System

10-Apr-2013 - As it inks a major commercial supply agreement, Unilife says its EZMix dual-chamber syringe will significantly cut reconstitution steps in combination therapy delivery. 

BMS to Shutter Ex-Amylin Facility - Redundancies Inevitable

09-Apr-2013 - Bristol-Myers Squibb says shuttering Amylin’s San Diego facilities will accelerate its diabetes R&D joint venture with AstraZeneca though approximately 300 jobs will be lost.

Further Hope for Oral Insulin as Israeli Delivery Tech Gets Patent

04-Apr-2013 - Jerusalem, Israel-based drugmaker Oramed Pharmaceuticals has been granted patent approval for its oral insulin technology by the Japanese Patent office.

Lilly's Second Insulin Injection Brings Total to $240m Over 5 Months

03-Apr-2013 - Lilly says another investment in its Indianapolis facility will add a second insulin cartridge-filling line and is driven by the increasing prevalence of diabetes.

Nypro to Build Delivery Device Plant in Ireland

02-Apr-2013 - Nypro has announced plans to build a delivery device plant in Waterford, Ireland and launched a recruitment drive.

Updated

Brass Particulates, Sealing Issues Cause Two More Hospira Injection Recalls

01-Apr-2013 - Hospira’s recall woes continued again late last week as the company pulled lots of its sodium chloride and diazepam injections. 

BD Forms Pharmaceutical Wing with New Prefilled Generic Injectables

28-Mar-2013 - BD says a brand new facility and sustainable pricing will allow the company to compete as it enters the generics market following FDA approval of its first injectable drug. 

Novo Nordisk One Step Closer to Long-Acting Oral Insulin

20-Mar-2013 - Novo Nordisk says its long-acting oral insulin could become a lead product following the successful completion of an early-stage trial.

Correction

'Flying Syringe' Puts Buzz Into Drug Delivery

18-Mar-2013 - A High School is using mosquitos to deliver vaccines as part of a project to develop a ‘flying syringe.’